Hexaom (ALHEX) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
9 Sep, 2026Executive summary
Revenue for H1 2025 was €306.3M, down 26.5% year-over-year, reflecting a cyclical low but with well-managed results and financial structure.
Operating income was €12.2M, down 14.1% year-over-year, with operating margin improving to 4.0% from 3.4% in H1 2024.
Net income attributable to the group was €5.4M, down 48.6% year-over-year, representing 1.8% of revenue.
The integration of Groupe HDV since January 2025 contributed positively to margins and results.
Strong commercial momentum and order growth across all business lines, especially in house construction.
Financial highlights
Revenue: €306.3M (H1 2025), down 26.5% year-over-year.
Operating income: €12.2M (H1 2025), down 14.1% year-over-year.
Net income: €5.4M (H1 2025), down 48.6% year-over-year.
Net cash position at June 30, 2025: €32.7M; cash and equivalents: €133.5M.
All business segments maintained positive operating margins.
Outlook and guidance
Revenue for 2025 is expected to decline by 10–15%, with operating profitability targeted above 3%.
Anticipation of strong revenue and earnings growth in 2026, supported by robust order book and diversification.
Vigilance maintained due to ongoing economic and geopolitical volatility.
Latest events from Hexaom
- H1 2026 saw double-digit revenue growth, margin expansion, and robust cash generation.ALHEX
H1 2026 - Revenue up 12.1% to €343.6M; 2026 outlook strong with 20% growth and higher profitability targeted.ALHEX
Q2 2026 TU - Q1 2026 revenue up 10.5% to €159.5M; 2026 outlook: 20% growth, >5% operating margin.ALHEX
Q1 2026 - 2025 revenue fell 15.4%, but margins rose and 2026 growth of 20% is forecast.ALHEX
H2 2025 - 2025 revenue fell 15.3% year-over-year, but strong order intake signals growth for 2026.ALHEX
Q4 2025 TU - Revenue down 21.3% Y/Y, but strong order intake and growth expected in 2026.ALHEX
Q3 2025 - Revenue declined 26.8% in H1 2025, but order intake surged, supporting a positive outlook.ALHEX
H1 2025 TU - Profitability and strong net cash position maintained despite a 24.5% revenue drop.ALHEX
H1 2024 - Revenue and profit declined sharply, but diversification and acquisitions support recovery.ALHEX
H2 2024